Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Drops By 92.6%

Sysmex Co. (OTCMKTS:SSMXY) was the target of a significant decrease in short interest in September. As of September 30th, there was short interest totalling 27,200 shares, a decrease of 92.6% from the September 15th total of 369,500 shares. Based on an average trading volume of 84,400 shares, the short-interest ratio is currently 0.3 days.

Sysmex Stock Down 1.1 %

SSMXY traded down $0.21 on Thursday, hitting $19.24. 28,531 shares of the company were exchanged, compared to its average volume of 112,357. Sysmex has a 12 month low of $14.38 and a 12 month high of $29.78. The company has a market cap of $12.11 billion, a PE ratio of 37.97 and a beta of 0.83. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.40 and a current ratio of 3.23. The stock’s fifty day moving average is $18.96 and its 200-day moving average is $17.30.

Sysmex (OTCMKTS:SSMXY) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.11 earnings per share (EPS) for the quarter. The business had revenue of $718.13 million during the quarter. Equities research analysts predict that Sysmex will post 0.65 EPS for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.